WFMPM
VRTX icon

Woodley Farra Manion Portfolio Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-370
Closed -$107K – 389
2020
Q2 		$107K Hold
370
– – 0.01% 105
2020
Q1 		$88K Buy
370
+175
+90% +$40.1K 0.01% 122
2019
Q4 		$43K Buy
+195
New +$39.5K ﹤0.01% 192

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's VRTX Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2020, closing a stake of 370 shares — an estimated $107K sold.

Woodley Farra Manion Portfolio Management first reported a position in VRTX in Q4 2019 and held it in 3 quarters. The position peaked at $107K in Q2 2020. 951 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Vertex Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 370 Vertex Pharmaceuticals shares in Q3 2020, an estimated $107K.
  • Woodley Farra Manion Portfolio Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Woodley Farra Manion Portfolio Management's Vertex Pharmaceuticals position peaked at $107K in Q2 2020.
  • 951 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.